Table 4 Demographic details for subgroup comparisons. Data are shown as mean (SD), except for gender
Sputum eosinophilia | Exacerbation frequency | ||||||||
|---|---|---|---|---|---|---|---|---|---|
≥ 1% (n = 11) | < 1% (n = 13) | p | ≥ 2% (n = 6) | < 2% (n = 18) | p | <2 (n = 10) | ≥2 (n = 13) | p | |
Age | 65.0 (6.7) | 64.5 (7.3) | 0.884 | 63.5 (8.3) | 65.2 (6.6) | 0.713 | 67.0 (5.2) | 66.5 (4.7) | 0.686 |
Gender (male/female) | 7/4 | 9/4 | 0.772 | 3/3 | 13/5 | 0.317 | 7/3 | 9/4 | 0.968 |
Cigarette pack years | 48.3 (19.8) | 39.7 (12.0) | 0.199 | 38.0 (14.1) | 45.5 (16.9) | 0.338 | 49.7 (27.9) | 49.9 (10.3) | 0.983 |
% predicted FEV1 | 51.5 (16.9) | 59.4 (9.3) | 0.131 | 58.2 (19.3) | 55.0 (11.7) | 0.713 | 52.9 (11.9) | 44.9 (14.3) | 0.120 |
ICS total daily dose (μg BDP equivalent) | 570 (797) | 818 (756) | 0.473 | 825 (826) | 300 (346) | 0.058 | 880 (855) | 1364 (1196) | 0.400 |